The integrity of clinical trials hinges on ensuring that each participant is unique to the study and does not enroll multiple times in the same trial or across different studies. Duplicate research subjects introduce significant risks, compromising data validity, regulatory compliance, and overall study success. While detection efforts at the study’s conclusion can identify such …
NEW YORK, March 19, 2024 /PRNewswire/ — ProofPilot, the industry’s only platform for clinical trial automation, guidance and flawless execution, is excited to announce its strategic partnership with Verified Clinical Trials (VCT), the world’s leading validated research participant registry and verification platform. This collaboration marks a significant milestone in improving data integrity by reducing the risk of ineligible patients. VCT …
Nonadherence in clinical trials remains a significant hurdle, leading to compromised data integrity, skewed results, and costly delays. One often overlooked but critical factor contributing to nonadherence is the presence of duplicate subjects and professional research subjects—individuals who enroll in multiple trials simultaneously or misrepresent their participation history. The Hidden Impact of Duplicate Subjects Nonadherence …
The global obesity epidemic continues to surge, leading to an unprecedented demand for effective treatments and numerous clinical trials. As a result, the clinical trial landscape is rapidly expanding, with numerous companies conducting a wide array of obesity-related studies. Among these, GLP-1 receptor agonists have emerged as a leading therapeutic option, prompting a significant increase …
The prevalence of duplicate participants in clinical trials poses significant risks, compromising the integrity of data and the safety of the patients involved. To delve into this matter, we spoke with Kerri Weingard, a seasoned veteran in the field and the co-founder of Verified Clinical Trials (VCT), who brings a wealth of knowledge and experience. In this …
January 30, 2025 07:07 ET | Source: Velocity Clinical Research, Inc.Follow DURHAM, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) — Velocity Clinical Research, the leading multi-specialty clinical research organization, has partnered with Verified Clinical Trials (VCT) to set a new benchmark for patient safety and data quality in clinical trials through a new technological implementation at Velocity’s 80+ …
In the dynamic world of clinical research, ensuring data integrity and participant safety is paramount. One of the most significant challenges faced by clinical trials today is the issue of duplicate subjects in clinical trials—participants who enroll in multiple studies simultaneously or consecutively without proper washout periods. This practice can jeopardize study outcomes, compromise data …
We’re excited to announce that Verified Clinical Trials (VCT) will be exhibiting and hosting a special panel discussion focused on the growing challenges of duplicate and professional subjects in vaccine clinical trials. Vaccine clinical trials present a unique set of challenges, particularly when it comes to subject verification. Unlike many other clinical studies, vaccine trials …
Interest in decentralized clinical trials has increased and has become quite popular. The adoption of these methods became acutely more appealing and necessary during the pandemic. Many research sites and clinical trial sponsors have adopted decentralized clinical trial methods. But decentralized clinical trials also come with unique challenges. To keep clinical trials safe, compliant, and effective, …
Vaccine clinical trials pose unique challenges with regards to duplicate research subjects or professional subjects. Typically, large numbers of subjects are dosed at the first visit in a vaccine clinical trial. There is no way for a site or principal investigator to adequately check if the research subject is a duplicate or professional subject. Subjects …
